Free Trial
CVE:RRL

Resolute Resources (RRL) Stock Price, News & Analysis

Resolute Resources logo
C$0.0050 -0.01 (-50.00%)
As of 10/10/2024

About Resolute Resources Stock (CVE:RRL)

Key Stats

Today's Range
C$0.01
C$0.01
50-Day Range
C$0.01
C$0.01
52-Week Range
C$0.01
C$0.47
Volume
10,000 shs
Average Volume
319,898 shs
Market Capitalization
C$346.45 thousand
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive RRL Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Resolute Resources and its competitors with MarketBeat's FREE daily newsletter.

RRL Stock News Headlines

Resolute Resources Ltd.
Buffett’s $325 Billion Cash Problem — Solved by Gold?
A bombshell announcement is just weeks away — and it could send shockwaves through the gold market. Most investors are still asleep… but not for long. Garrett Goggin’s latest research reveals how you can “front-run” the greatest investor alive by positioning in four small miners sitting on up to 100X potential upside. When this hits the news — it’ll be too late.
See More Headlines

RRL Stock Analysis - Frequently Asked Questions

Resolute Resources' stock was trading at C$0.01 at the beginning of the year. Since then, RRL shares have increased by 0.0% and is now trading at C$0.01.

Shares of RRL stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.

Based on aggregate information from My MarketBeat watchlists, some other companies that Resolute Resources investors own include Avino Silver & Gold Mines (ASM), BlackBerry (BB), Applied Optoelectronics (AAOI), Ambev (ABEV), Aben Resources (ABN), Aclaris Therapeutics (ACRS) and Adaptimmune Therapeutics (ADAP).

Industry, Sector and Symbol

Stock Exchange
CVE
Sector
Energy
Industry
Oil & Gas E&P
Sub-Industry
N/A
Current Symbol
CVE:RRL
CIK
N/A
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
C($0.04)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-C$2.56 million
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
-63.01%
Return on Assets
-23.59%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
1.10
Quick Ratio
10.30

Sales & Book Value

Annual Sales
C$2.18 million
Price / Sales
0.16
Cash Flow
C$0.00 per share
Price / Cash Flow
7.14
Book Value
C$0.09 per share
Price / Book
0.06

Miscellaneous

Outstanding Shares
69,290,000
Free Float
N/A
Market Cap
C$346.45 thousand
Optionable
Not Optionable
Beta
-2.56
Options Trading Made Easy - Download Now Cover

Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.

Get This Free Report

This page (CVE:RRL) was last updated on 7/12/2025 by MarketBeat.com Staff
From Our Partners